Atlas Trials

An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS

Clinical trial NCT05835518 · RECRUITING

Trial details

NCT number
NCT05835518
Sponsor
Yuhan Corporation
Status
RECRUITING
Study type
OBSERVATIONAL
Rheumatoid ArthritisAnkylosing Spondylitis
Start date
2023-01-26
Primary completion
2025-12-31
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.